Although they have shown that their antibody has the capacity to increase muscle mass in vivo using a steroid-mediated atrophy mouse model, they did not compare the effects of their antibody with those of anti-mature myostatin antibodies that have GDF11 cross-reactivity. Here, GDF11 is linked to Atrophy.